Table 3.
Satisfaction, perceived suitability and the likelihood of future use and duration of intended use reported by current and past users of injectables or implants by type of side effect experienced (percentages)
| Current users |
Past users |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Bleeding problems only | Nonbleeding only | Both bleeding and nonbleeding | No side effects | p value | Bleeding problems only | Nonbleeding only | Bot bleeding and nonbleeding | No side effects | p value | |
| Injectables | ||||||||||
| % satisfied with method | 89.0 | 81.5 | 71.1 | 98.6 | <.001 | 58.0 | 43.9 | 23.7 | 73.0 | <.001 |
| % who think method is suitable for someone like her | 94.1 | 92.6 | 87.3 | 98.0 | .003 | 66.8 | 65.2 | 37.9 | 81.0 | <.001 |
| % very or somewhat likely to use in the future | NA | NA | NA | NA | NA | 56.7 | 57.6 | 38.7 | 73.6 | <.001 |
| % intending to stop using the method within 2 years | 19.7 | 14.8 | 27.0 | 23.3 | .481 | NA | NA | NA | NA | NA |
| Number of women (N) | 236 | 27 | 149 | 146 | 319 | 66 | 406 | 163 | ||
| Implants | ||||||||||
| % satisfied with method | 85.5 | 69.6 | 62.8 | 97.3 | <.001 | 44.6 | 25.0 | 19.2 | 50.0 | <.001 |
| % who think method is suitable for someone like her | 85.5 | 93.5 | 74.4 | 95.9 | <.001 | 45.7 | 43.8 | 20.0 | 56.1 | <.001 |
| % very or somewhat likely to use in the future | NA | NA | NA | NA | NA | 39.1 | 28.1 | 25.4 | 57.0 | <.001 |
| % intending to stop using the method within 2 years | 21.5 | 34.8 | 25.6 | 21.8 | .313 | NA | NA | NA | NA | NA |
| Number of women (N) | 145 | 46 | 86 | 147 | 92 | 32 | 130 | 114 | ||
NA, not asked.